APVO compared with BNGO: revenue, margins and what each company keeps, and the suppliers and customers both name

APVOAptevo Therapeutics Inc.

Mkt capRevenueRevenue

BNGOBionano Genomics, Inc.

Mkt capRevenueRevenue

Compare

APVOAptevo Therapeutics Inc.

BNGOBionano Genomics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

APVO1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−13.53%—

BNGO1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+2.59%—

= impliedAPVO realized, solidBNGO realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

APVOAptevo Therapeutics Inc.

1.31▼−3.68%· post 1.41

Mkt cap$2.4MRevenue—Revenue—

BNGOBionano Genomics, Inc.

1.15▼−4.17%· post 1.18

ClosedOct 30 '26

Mkt cap$13.5MRevenue$8MQ2 FY26Revenue$29MFY25

Compare

ClosedOct 30 '26

APVOAptevo Therapeutics Inc.

BNGOBionano Genomics, Inc.

1.31▼−3.68%post 1.41

Price

1.15▼−4.17%post 1.18

$2.4M

Mkt cap

$13.5M

—

Revenue

$8MQ2 FY26

—

Revenue

$29MFY25

APVO1.31▼−3.68%vsBNGO1.15▼−4.17%ClosedOct 30 '26